Nature Biotechnology, Published online: 09 July 2026; doi:10.1038/s41587-026-03211-3

From virtual patients to simulated cells and organs-on-chips, digital twins are forecasting disease and guiding drug development. Scientists now must figure out how to define, validate and deploy these models.